Working… Menu

A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02632448
Recruitment Status : Recruiting
First Posted : December 16, 2015
Last Update Posted : September 16, 2020
Information provided by (Responsible Party):
Esperas Pharma Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Actual Primary Completion Date : March 27, 2020
Estimated Study Completion Date : June 2021